$BPTH +126%

$BPTH is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target specific protein inhibition for any gene product that is over-expressed in disease.

They release today the news of a US patent for their technology.
Here is the link of the news.

I saved the graph of the day here.

 

Here is the 30 day graph.

You May Also Like

$ COSM + 72% and bring with him $AMIH for a + 166%

$SWVL + 115% on the day on NO NEWS.

$ICCM + 177% today

$SLNO + 103% on $60M financing news.

Leave a Reply

Your email address will not be published. Required fields are marked *

EMAIL SIGNUP